Insilico Medicine (Series E)
Funding Details
- Awarder
- Inbox
- Date Award
- April 01, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $110,000,000
Company Info
- Founders
- Alex Zhavoronkov
- Company Description
- Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
- Market
- Drug Discovery and Development
- Location
- Cambridge, MA, USA
- Coinvestors
- Value Partners Group